NEW YORK (GenomeWeb) – Eisai and Sysmex said yesterday that they have entered into a comprehensive non-exclusive collaboration agreement to create new diagnostics for dementia.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.